The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.Vise andre og tillknytning
2004 (engelsk)Inngår i: In Vivo, ISSN 0258-851X, Vol. 18, nr 5, s. 615-20Artikkel i tidsskrift (Fagfellevurdert) Published
sted, utgiver, år, opplag, sider
2004. Vol. 18, nr 5, s. 615-20
Emneord [en]
Adenocarcinoma/*immunology/mortality/pathology/therapy, Antibodies; Neoplasm/*blood, Carcinoma; Squamous Cell/*immunology/mortality/pathology/therapy, Combined Modality Therapy, Enzyme-Linked Immunosorbent Assay, Esophageal Neoplasms/*immunology/mortality/pathology/therapy, Female, Humans, Male, Palliative Care, Preoperative Care, Protein p53/*immunology, Survival Rate
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-69911PubMedID: 15523902OAI: oai:DiVA.org:uu-69911DiVA, id: diva2:97822
2005-05-272005-05-272011-01-12